![]() ![]() In order to do so, there are two options:ġ. Replace the X509Anchors file It appears that in some cases, the X509Anchors is not properly installed by the Mac OS X 10.4.9 update, and replacing it with a valid copy can resolve issues with secure site access. I also created a new user and tried to go to a secure site and get the same error message." ![]() I get the error message: Safari can?t open the page ? because it couldn't establish a secure connection to the server ?I have deleted the plist file, reset Safari, cleared the different cache files and reinstalled the proper Combo updater. Now I have one Intel iMac and one Power PC where Safari won't load any https: sites. "I updated 15 Macs at work, both power PC and Intel. Progress on the margins front amid cost rationalisation measures and decline in R&D expenses as percentage of salesĭisclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint.Some users are reporting problems with access to secure sites after applying the Mac OS X 10.4.9 update. It has also forayed into consumer health segment focusing on Rx-OTC switch products led by two brands, Candid and Scalpe+ In India, it is the market leader in dermatology and improving its presence in respiratory, CVS, anti-infectives and anti-diabetics, in particular. Traction for Ryaltris in global markets along with the launch in the US In the US, regulatory clearance for newly commissioned US based Monroe facility will be the key determinant for future launches ICICI Direct analysts note has set a target price of ₹440 per share on Glenmark.Īmong the key triggers for the future performance in Glenmark as per ICICI Direct's note are: Post Q1FY23 research note, ICICI Direct analysts said, "Glenmark’s share price has de-grown by ~0.9x over past three years (from ₹416 in August 2019 to ₹388 levels in August 2022)," adding, "maintain HOLD as we await EBITDA margin sustainability besides persisting US base business pressure amid regulatory hurdles at Monroe facility." Reported EBITDA was at ₹431.6 crore in the quarter that ended June 30, 2022, with margins of 15.5%. Adjusted EBITDA was at ₹472.6 crore in the quarter as against ₹573.6 crore in the previous corresponding quarter, with margins of 17%. Glenmark had stated that when viewed without taking into account the global sales of COVID-related products in the first quarter of FY 2021-22, the base business shows the year-on-year growth of 10.4% in the current fiscal.Ĭonsolidated Profit After Tax (PAT) during Q1FY23 was at ₹211.1 crore as compared to ₹306.5 crore in the previous corresponding quarter, registering a decline of (31%) YoY. In Q1FY23, Glenmark Pharma reported consolidated revenue of ₹2,777.3 crore against ₹2,964.9 crore recording a de-growth of (6.3%). Should you invest in Glenmark Pharma shares? Further, shareholders will have to pay 20% TDS if they fall under the 206AB category. While the TDS will be 20% if PAN is not updated or valid. TDS is 10% for shareholders who have updated their Permanent Account Number (PAN) in their Demat account. Under the section 206AB, the tax shall be deductible at the higher rates - if the deductee has not filed the return of income for both FY20 and FY21 the due date to file the return has expired or the aggregate amount of tax deducted and collected at source is ₹50,000 or more in each of these two previous years. However, no tax shall be deducted on the dividend payable to a resident individual if the total dividend to be received by them during the Financial Year 2022-23 does not exceed ₹5,000.Īlso, if the resident individual shareholder provides a declaration in Form 15G/ Form 15H, no TDS shall be applicable. Glenmark highlighted that as per section 194 of the income tax act, 1961 every company is required to deduct tax at source from the dividend paid to resident shareholders as per prescribed rates. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |